Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era

• Kittiyod Poovorawan ,

  * E-mail: kittiyod.poo@mahidol.ac.th

  Affiliation Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Wirichada Pan-ngum,

  Affiliations Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Mathematical and Economic Modelling Group, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Lisa J. White,

  Affiliations Mathematical and Economic Modelling Group, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK

  ⨯
• Ngamphol Soonthornworasiri,

  Affiliation Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Polrat Wilairatana,

  Affiliation Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Rujipat Wasitthankasem,

  Affiliation Department of Pediatrics, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  ⨯
• Pisit Tangkijvanich,

  Affiliation Department of Biochemistry, Research Unit of Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  ⨯
• Yong Poovorawan

  Affiliation Department of Pediatrics, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  ⨯